---
id: alphafold2
kind: breakthrough
title: AlphaFold2 — Protein Structure Prediction at Scale
updated: 2026-10-05
sources:
  - id: alphafold-nature
    url: https://www.nature.com/articles/s41586-021-03819-2
    title: Highly accurate protein structure prediction with AlphaFold (Jumper et al., 2021)
    checked: 2026-10-05
  - id: alphafold-deepmind
    url: https://deepmind.google/science/alphafold/
    title: AlphaFold — Google DeepMind project and impact page
    checked: 2026-10-05
  - id: alphafold-db
    url: https://alphafold.ebi.ac.uk/
    title: AlphaFold Protein Structure Database — EMBL-EBI and Google DeepMind
    checked: 2026-10-05
related:
  - breakthroughs/transformer.md
  - breakthroughs/imagenet-alexnet.md
contributors:
  - people/john-jumper.md
  - people/demis-hassabis.md
---
## What was blocked
Experimental structure determination is labor-intensive, and known structures covered only a small fraction of protein sequences. The bottleneck limited structural biology and downstream investigation. Protein structure prediction had a long history, including community benchmarks such as CASP; the challenge was improving accuracy and coverage enough for practical use. [Source: alphafold-nature]

## What changed
AlphaFold2 combined learned representations of sequences and residue relationships with iterative refinement to predict 3D structures. In CASP14 it achieved accuracy competitive with experimental structures for many targets, according to the authors. The 2021 paper has 24 authors, led by John Jumper and Demis Hassabis; credit belongs to the team and prior structural-biology community, not two people alone. Google DeepMind and EMBL-EBI subsequently made a large predicted-structure database openly accessible. [Sources: alphafold-nature, alphafold-deepmind, alphafold-db]

## Why it mattered — interpretation
The breakthrough connected a benchmarked prediction capability to broad access: a research result became infrastructure scientists could query. It reduced a structural-information bottleneck, enabling new hypotheses and prioritization, rather than replacing experimental biology. This is an impact interpretation supported by the paper and database/project materials.

## Practical leverage
Use predicted structures to generate or prioritize hypotheses, inspect likely domains and residues, and decide where experiments may be most informative. Check confidence metrics and biological context; treat the model as a guide to experiments rather than a definitive observation. For an AI deployment, the lesson is to pair a capability with accessible, well-documented infrastructure and domain-specific validation.

## Limits and open questions
Predicted structures are not experimental structures, and confidence varies across residues and regions. A static structure does not fully describe dynamics, complexes, cellular context, or function. Database coverage and model suitability vary by protein. Downstream biological conclusions still need domain expertise and, where appropriate, experimental validation.

## Sources
- [alphafold-nature] Primary paper: https://www.nature.com/articles/s41586-021-03819-2
- [alphafold-deepmind] Project history, methods, and case studies: https://deepmind.google/science/alphafold/
- [alphafold-db] Searchable database: https://alphafold.ebi.ac.uk/